Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22211058 | 0.91 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL25456242 | 0.88 | PDK2 (0.37) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL21793198 | 0.85 | PDK2 (0.35) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL26156855 | 0.85 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL26547819 | 0.85 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL26547851 | 0.85 | ESR1 (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL20869356 | 0.84 | MEN1 (0.41) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL30082736 | 0.84 | MEN1 (0.41) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16922975 | 0.83 | CYP2A6 (0.48) | CYP2A6PDK2KDM4EMEN1LMNA | |
| SCHEMBL29849821 | 0.82 | MEN1 (0.47) | PDK2KDM4EMEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230354697-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| US-20230354697-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| WO-2021154041-A1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | 주식회사 엘지화학 | 2021-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354697-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | NOTUM, SEM1, ORMDL3 | CYP2A6 558/4885PDK2 3851/4885KDM4E 1312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.